111 related articles for article (PubMed ID: 30509085)
1. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway.
Zeng CX; Fu SB; Feng WS; Zhao JY; Li FX; Gao P
Neoplasma; 2019 Jan; 66(1):46-53. PubMed ID: 30509085
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of EPS8L3 promotes cell proliferation by inhibiting the transactivity of FOXO1 in HCC.
Zeng CX; Tang LY; Xie CY; Li FX; Zhao JY; Jiang N; Tong Z; Fu SB; Wen FJ; Feng WS
Neoplasma; 2018 Sep; 65(5):701-707. PubMed ID: 29940761
[TBL] [Abstract][Full Text] [Related]
3. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism.
Chiu AP; Tschida BR; Sham TT; Lo LH; Moriarity BS; Li XX; Lo RC; Hinton DE; Rowlands DK; Chan CO; Mok DKW; Largaespada DA; Warner N; Keng VW
Mol Cancer Res; 2019 Jul; 17(7):1582-1593. PubMed ID: 30975706
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
[TBL] [Abstract][Full Text] [Related]
6. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
Xu H; Li G; Yue Z; Li C
Mol Med Rep; 2016 Jun; 13(6):5223-9. PubMed ID: 27108614
[TBL] [Abstract][Full Text] [Related]
7. Gα12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation.
Jung HS; Seo YR; Yang YM; Koo JH; An J; Lee SJ; Kim KM; Kim SG
Cell Signal; 2014 Jul; 26(7):1456-65. PubMed ID: 24631529
[TBL] [Abstract][Full Text] [Related]
8. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X
Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
[TBL] [Abstract][Full Text] [Related]
10. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
12. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.
Li CF; Zhang WG; Liu M; Qiu LW; Chen XF; Lv L; Mei ZC
Oncotarget; 2016 Jul; 7(28):44161-44170. PubMed ID: 27329843
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
16. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
Yao Y; Dou C; Lu Z; Zheng X; Liu Q
Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
18. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]